How diabetes disrupts the immune system
21 April, 2016Western Australian scientists have led new research into how type 1 diabetes disrupts the body's immune system — a finding that could help focus the search for a cure for the condition.
A protein to reverse cognitive decline
19 April, 2016Scientists have discovered that a protein called IL-33 can reverse Alzheimer's disease-like pathology and cognitive decline in mice, giving hope to the 65 million people who are projected to develop the disease by 2030.
Innate exceeds SPMS trial recruitment target
13 April, 2016Innate Immunotherapeutics has closed enrolment in its Phase 2B efficacy trial of MIS416 in patients with secondary progressive multiple sclerosis, having this week exceeded the original recruitment target of 90 subjects.
Grand Challenges Explorations Round 17 open
06 April, 2016The Bill & Melinda Gates Foundation is currently accepting applications for the 17th round of Grand Challenges Explorations, an initiative to encourage innovative and unconventional global health and development solutions.
What's your risk of breaking a bone?
06 April, 2016Researchers from the University of Southampton have led a study into the risks of an individual experiencing a fracture in their lifetime.
Malaria from the age of the dinosaurs?
04 April, 2016A researcher from Oregon State University has claimed that malaria evolved in insects at least 100 million years ago. His research suggests that the first vertebrate hosts of this disease were probably reptiles, which at that time would have included the dinosaurs.
MoU to strengthen biomedical science partnership
31 March, 2016The Australian Institute of Medical Scientists and the UK Institute of Biomedical Science have signed a memorandum of understanding that is intended to strengthen the partnership between the two organisations.
Antibody assets to be developed for cancer treatment
29 March, 2016Shares in Patrys rose almost 30% as the company announced that it will develop and commercialise as anticancer agents a portfolio of preclinical novel anti-DNA antibodies and antibody fragments/variants discovered at Yale University.
Phase IIb Parkinson's trial approved
24 March, 2016Living Cell Technologies has received approval from the Auckland Hospital Research Review Committee for its Phase IIb clinical trial of NTCELL for Parkinson's disease.
$20m in financing for blood-based bowel cancer test
23 March, 2016OneVentures has closed a $19.7 million financing round for Clinical Genomics, an Australian company set to launch its next-generation blood-based diagnostic tool for colorectal cancer.
Dedicated cancer research centre opening soon
16 March, 2016The Centenary Institute and the ACRF have announced the first dedicated cancer research centre in the RPA Hospital and University of Sydney precinct.
Positive data from bladder cancer trial
15 March, 2016Viralytics announced positive data from a clinical trial of its lead drug candidate, CAVATAK, at the 31st Annual European Association of Urology Congress held in Munich.
The protein that keeps cancer cells alive
08 March, 2016Researchers from the Walter and Eliza Hall Institute have discovered a protein that is key to the development of blood cancers caused by a common genetic error.
The mechanism behind neurodegeneration
07 March, 2016Researchers claim that a previously undiscovered mechanism in a key group of neurons affected in a neurodegenerating brain is the driver of the continuing cycle of neuronal cell death.
Australian-developed bowel cancer test approved in China
04 March, 2016Clinical Genomics has received China Food and Drug Administration approval for the commercialisation of InSure FIT, its faecal immunochemical test for colorectal cancer.
